3,4-Methylenedioxy-N-methoxyamphetamine
From Infogalactic: the planetary knowledge core
(Redirected from MDMEO)
![]() |
|
Names | |
---|---|
IUPAC name
1-(1,3-benzodioxol-5-yl)-N-methoxypropan-2-amine
|
|
Identifiers | |
74698-48-9 ![]() |
|
ChemSpider | 21106333 ![]() |
Jmol 3D model | Interactive image |
|
|
|
|
Properties | |
C11H15NO3 | |
Molar mass | 209.25 g·mol−1 |
Vapor pressure | {{{value}}} |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
![]() ![]() ![]() |
|
Infobox references | |
3,4-Methylenedioxy-N-methoxyamphetamine (MDMEO, MDMEOA, or MDMeOA) is a lesser-known psychedelic drug and a substituted amphetamine. It is also the N-methoxy analogue of MDA. MDMEO was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 180 mg. MDMEO may be found as white crystals. It produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MDMEO.
See also
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
External links
<templatestyles src="Asbox/styles.css"></templatestyles>